These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 10933933)
1. Reports of adenovector "death" are greatly exaggerated. Brenner M Mol Ther; 2000 Mar; 1(3):205. PubMed ID: 10933933 [No Abstract] [Full Text] [Related]
2. Basic research tries to decrease the risks of translational medicine. Cavazzana-Calvo M Gene Ther; 2009 Mar; 16(3):309-10. PubMed ID: 19279646 [No Abstract] [Full Text] [Related]
3. The controversial role of adenoviral-derived vectors in gene therapy programs: where do we stand? Romano G Drug News Perspect; 2006 Mar; 19(2):99-106. PubMed ID: 16628265 [TBL] [Abstract][Full Text] [Related]
4. Immune responses against adenoviral vectors and their transgene products: a review of strategies for evasion. Schagen FH; Ossevoort M; Toes RE; Hoeben RC Crit Rev Oncol Hematol; 2004 Apr; 50(1):51-70. PubMed ID: 15094159 [TBL] [Abstract][Full Text] [Related]
6. Gene therapy. Blood test flags agent in death of Penn subject. Bostanci A Science; 2002 Jan; 295(5555):604-5. PubMed ID: 11809948 [No Abstract] [Full Text] [Related]
7. Repeated administration of adenovector in the eye results in efficient gene delivery. Hamilton MM; Brough DE; McVey D; Bruder JT; King CR; Wei LL Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):299-305. PubMed ID: 16384977 [TBL] [Abstract][Full Text] [Related]
8. Adenoviral strategies for the gene therapy of cancer. Relph KL; Harrington KJ; Pandha H Semin Oncol; 2005 Dec; 32(6):573-82. PubMed ID: 16338423 [TBL] [Abstract][Full Text] [Related]
10. Development of high-capacity adenoviral vectors for gene therapy. Kochanek S Thromb Haemost; 1999 Aug; 82(2):547-51. PubMed ID: 10605749 [No Abstract] [Full Text] [Related]
11. Inflammation and adaptive immune responses to adenoviral vectors injected into the brain: peculiarities, mechanisms, and consequences. Lowenstein PR; Castro MG Gene Ther; 2003 Jun; 10(11):946-54. PubMed ID: 12756415 [No Abstract] [Full Text] [Related]
12. Tumor-targeting of viral vectors for cancer gene therapy by using antibodies or their genes against tumor-associated antigens. Kuroki M; Kuroki M; Shibaguchi H; Hachimine K; Kinugasa T; Badran A Anticancer Res; 2004; 24(5C):3373-7. PubMed ID: 15515434 [TBL] [Abstract][Full Text] [Related]